MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS

Aim of study: multiplex analysis of the levels of biomarkers of neoangiogenesis and inflammation in cardiac transplant recipients. Materials and methods. 59 pts. with heart failure III–IV according to NYHA FC, waiting for a heart transplant, aged 22 to 73 years, 48 males and 11 females. 41 recipient...

Full description

Bibliographic Details
Main Authors: O. P. Shevchenko, E. A. Stakhanova, O. E. Gichkun, R. M. Kurabekova, I. I. Muminov, A. O. Shevchenko
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2015-04-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/492
_version_ 1826546404779098112
author O. P. Shevchenko
E. A. Stakhanova
O. E. Gichkun
R. M. Kurabekova
I. I. Muminov
A. O. Shevchenko
author_facet O. P. Shevchenko
E. A. Stakhanova
O. E. Gichkun
R. M. Kurabekova
I. I. Muminov
A. O. Shevchenko
author_sort O. P. Shevchenko
collection DOAJ
description Aim of study: multiplex analysis of the levels of biomarkers of neoangiogenesis and inflammation in cardiac transplant recipients. Materials and methods. 59 pts. with heart failure III–IV according to NYHA FC, waiting for a heart transplant, aged 22 to 73 years, 48 males and 11 females. 41 recipient (30 men and 11 women) had dilated cardiomyopathy, 18 – coronary heart disease (CHD). The concentration of VEGF-A, VEGF-D, PlGF, PDGF-BB, FGF, sCD40L, MCP-1 was measured using xMAP technology, the sets of reagents Simplex ProcartaPlexTM (Affymetrix, USA). Results. There are four levels of seven biomarkers of neoangiogenesis and inflammation method for multiplex analysis in patients with heart failure. A year after transplantation, the mean levels of biomarkers VEGF-A (p = 0.001), PDGF-BB (p = 0.018), MCP-1 (p = 0.003) was significantly decreased, and the others had a tendency to decrease relative to the level before transplantation. It was shown individual differences of levels of VEGF-A, VEGF-D and PlGF before and after transplantation. There were found different dynamics of the concentrations of biomarkers and growth factors before and after heart transplantation in patients with cardiovascular complications and without them. Conclusion. Multiplex analysis allows to measure the concentration range of analyte biomarkers of neoangiogenesis, inflammation in one sample of blood serum of patients with severe heart failure and after transplantation. There are marked individual differences in the concentration of biomarkers in different clinical situations that may have clinical significance in the conduct and supervision of recipients after transplantation.
first_indexed 2024-04-10T00:52:41Z
format Article
id doaj.art-26eba2a182304532bbbba3baea70bead
institution Directory Open Access Journal
issn 1995-1191
language Russian
last_indexed 2025-03-14T05:33:13Z
publishDate 2015-04-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Вестник трансплантологии и искусственных органов
spelling doaj.art-26eba2a182304532bbbba3baea70bead2025-03-05T14:11:48ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovВестник трансплантологии и искусственных органов1995-11912015-04-01171121710.15825/1995-1191-2015-1-12-17427MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTSO. P. Shevchenko0E. A. Stakhanova1O. E. Gichkun2R. M. Kurabekova3I. I. Muminov4A. O. Shevchenko5V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation N.I. Pirogov Russian National Research Medical University, Moscow, Russian FederationAim of study: multiplex analysis of the levels of biomarkers of neoangiogenesis and inflammation in cardiac transplant recipients. Materials and methods. 59 pts. with heart failure III–IV according to NYHA FC, waiting for a heart transplant, aged 22 to 73 years, 48 males and 11 females. 41 recipient (30 men and 11 women) had dilated cardiomyopathy, 18 – coronary heart disease (CHD). The concentration of VEGF-A, VEGF-D, PlGF, PDGF-BB, FGF, sCD40L, MCP-1 was measured using xMAP technology, the sets of reagents Simplex ProcartaPlexTM (Affymetrix, USA). Results. There are four levels of seven biomarkers of neoangiogenesis and inflammation method for multiplex analysis in patients with heart failure. A year after transplantation, the mean levels of biomarkers VEGF-A (p = 0.001), PDGF-BB (p = 0.018), MCP-1 (p = 0.003) was significantly decreased, and the others had a tendency to decrease relative to the level before transplantation. It was shown individual differences of levels of VEGF-A, VEGF-D and PlGF before and after transplantation. There were found different dynamics of the concentrations of biomarkers and growth factors before and after heart transplantation in patients with cardiovascular complications and without them. Conclusion. Multiplex analysis allows to measure the concentration range of analyte biomarkers of neoangiogenesis, inflammation in one sample of blood serum of patients with severe heart failure and after transplantation. There are marked individual differences in the concentration of biomarkers in different clinical situations that may have clinical significance in the conduct and supervision of recipients after transplantation.https://journal.transpl.ru/vtio/article/view/492heart transplantationmultiplex analysisvegfmcp-1pdgf
spellingShingle O. P. Shevchenko
E. A. Stakhanova
O. E. Gichkun
R. M. Kurabekova
I. I. Muminov
A. O. Shevchenko
MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
Вестник трансплантологии и искусственных органов
heart transplantation
multiplex analysis
vegf
mcp-1
pdgf
title MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
title_full MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
title_fullStr MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
title_full_unstemmed MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
title_short MULTIPLEX ANALYSIS OF BIOMARKERS OF NEOANGIOGENESIS AND INFLAMMATION IN HEART TRANSPLANT RECIPIENTS
title_sort multiplex analysis of biomarkers of neoangiogenesis and inflammation in heart transplant recipients
topic heart transplantation
multiplex analysis
vegf
mcp-1
pdgf
url https://journal.transpl.ru/vtio/article/view/492
work_keys_str_mv AT opshevchenko multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients
AT eastakhanova multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients
AT oegichkun multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients
AT rmkurabekova multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients
AT iimuminov multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients
AT aoshevchenko multiplexanalysisofbiomarkersofneoangiogenesisandinflammationinhearttransplantrecipients